2019 International Congress Archives - Page 44 of 217

Clonazepam as a cure or a cause? : Withdrawal Emergent Syndrome

S. Raju, K. Vyas (Bangalore, India)
Clostridium Difficile Infection and Risk of Parkinson’s Disease: A Swedish Population-Based Cohort Study

X. Kang, A. Ploner, J. Ludvigsson, D. Williams, N. Pedersen, K. Wirdefeldt (Solna, Sweden)
Co-administration of levodopa and zonisamide reduces the serotonin transporter expression in a rat model of Parkinson’s disease

R. Tohge, S. Kaneko, S. Morise, M. Oki, M. Nakamura, N. Takenouchi, H. Kusaka (Hirakata, Japan)
Cockayne Syndrome manifesting as late adult onset cerebellar ataxia: expanding the phenotype

R. Chuang (Seattle, WA, USA)
Cognition and Gait in Parkinson’s Disease

A. Fatima (Lahore, Pakistan)
Cognitive ability characterization of rat model with mutated alpha-synuclein overexpression

C. Laloux, C. Lachaud, K. Timmerman, E. Bezard, R. Bordet, D. Devos (Lille, France)
Cognitive and psychiatric course in the initial lustrum of Parkinson disease: the glass is half full

D. Weintraub, C. Caspell-Garcia, H. Cho, T. Simuni, A. Siderowf, C. Coffey, D. Aarsland, R. Alcalay, L. Chahine, J. Eberling, A. Espay, J. Hamilton, J. Leverenz, I. Litvan, I. Richard, L. Rosenthal, M. York (Philadelphia, PA, USA)
Cognitive changes after deep brain stimulation of the subthalamic nucleus in Parkinson’s disease: A longitudinal study.

J. Mana, F. Růžička, A. Fečíková, E. Růžička, D. Urgošík, R. Jech, O. Bezdicek (Prague, Czech Republic)
Cognitive complaint in Parkinson’s disease patients with normal cognition: Canary in the coal mine?

R. Purri, L. Brennan, J. Rick, S. Xie, B. Deck, L. Chahine, N. Dahodwala, A. Chen-Plotkin, J. Duda, J. Morley, R. Akhtar, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)
Cognitive dysfunction can predict the body weight loss in patients with Parkinson’s disease

RW. Ou, QQ. Wei, YB. Hou, XQ. Yuan, HF. Shang (Chengdu, China)